First case of hemophagocytic lymphohistiocytosis secondary to cabozantinib with checkpoint inhibitors.

Azari, Arianna E; Stratton, Richard; Singh, Animesh

Azari, Arianna E; Stratton, Richard; Singh, Animesh.

Affiliation

Azari AE; Centre for Rheumatology, Royal Free Hospital and University College Medical School, London, UK.
Stratton R; Centre for Rheumatology, Royal Free Hospital and University College Medical School, London, UK.
Singh A; Centre for Rheumatology, Royal Free Hospital and University College Medical School, London, UK.

Rheumatology (Oxford) ; 60(5): e167-e168, 2021 05 14.

Article in En | MEDLINE | ID: mdl-33280022

Subject(s)

Anilides/adverse effects; Antineoplastic Agents, Immunological/adverse effects; Immune Checkpoint Inhibitors/adverse effects; Ipilimumab/adverse effects; Lymphohistiocytosis, Hemophagocytic/chemically induced; Nivolumab/adverse effects; Pyridines/adverse effects; Carcinoma, Renal Cell/drug therapy; Humans; Kidney Neoplasms/drug therapy; Male; Middle Aged

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Lymphohistiocytosis, Hemophagocytic / Ipilimumab / Antineoplastic Agents, Immunological / Nivolumab / Immune Checkpoint Inhibitors / Anilides Limits: Humans / Male / Middle aged Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2021 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google